chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Ventricular drainage
Clinical narrative: Patient presented to the ED around 10pm on 4/21, ~one week after her J&J COVID vaccine (exact date of initial vaccination not confirmed but was reportedly 1 week prior) with abdominal pain and headache. She was found to have thrombocytopenia (Plt 38) on presentation as well as renal and ovarian vein thrombosis. CT head showed a large right frontal intraparenchymal hemorrhage. She was taken for urgent craniotomy on 9/5 with EVD placement. Brain tissue was noted to have bleeding spots unresponsive to cautery and requiring local hemostatic agents. Repeat imaging showed worsening infarction. She had continued elevated intracranial pressures, so was taken back to the OR on the morning of 9/6 for bilateral EVD placement to help relieve pressure. Given her thrombocytopenia, thrombosis, significantly elevated D-dimer, low fibrinogen, and +HIT Ab test, she was diagnosed with vaccine-induced thrombocytopenia and thrombosis (VITT). She was started on IVIG 1g/kg daily  x 2 days,  bivalirudin with supportive transfusions to maintain goal plts >50K, fibrinogen > 150. Despite this, her neurologic status deteriorated due to elevated pressures, clotting off of her EVDs, and ultimately was declared brain dead in the afternoon on 9/7.  Family withdrew supportive care and patient passed at 3:57PM on 9/7/21.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient presented to the ED around 10pm on 4/21, ~one week after her J&J COVID vaccine (exact date of initial vaccination not confirmed but was reportedly 1 week prior) with abdominal pain and headache. She was found to have thrombocytopenia (Plt 38) on presentation as well as renal and ovarian vein thrombosis. CT head showed a large right frontal intraparenchymal hemorrhage. She was taken for urgent craniotomy on 9/5 with EVD placement. Brain tissue was noted to have bleeding spots unresponsive to cautery and requiring local hemostatic agents. Repeat imaging showed worsening infarction. She had continued elevated intracranial pressures, so was taken back to the OR on the morning of 9/6 for bilateral EVD placement to help relieve pressure. Given her thrombocytopenia, thrombosis, significantly elevated D-dimer, low fibrinogen, and +HIT Ab test, she was diagnosed with vaccine-induced thrombocytopenia and thrombosis (VITT). She was started on IVIG 1g/kg daily  x 2 days,  bivalirudin with supportive transfusions to maintain goal plts >50K, fibrinogen > 150. Despite this, her neurologic status deteriorated due to elevated pressures, clotting off of her EVDs, and ultimately was declared brain dead in the afternoon on 9/7.  Family withdrew supportive care and patient passed at 3:57PM on 9/7/21.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Haemorrhage intracranial, Imaging procedure, Infarction, Laboratory test, Platelet count decreased
Clinical narrative: Patient presented to the ED around 10pm on 4/21, ~one week after her J&J COVID vaccine (exact date of initial vaccination not confirmed but was reportedly 1 week prior) with abdominal pain and headache. She was found to have thrombocytopenia (Plt 38) on presentation as well as renal and ovarian vein thrombosis. CT head showed a large right frontal intraparenchymal hemorrhage. She was taken for urgent craniotomy on 9/5 with EVD placement. Brain tissue was noted to have bleeding spots unresponsive to cautery and requiring local hemostatic agents. Repeat imaging showed worsening infarction. She had continued elevated intracranial pressures, so was taken back to the OR on the morning of 9/6 for bilateral EVD placement to help relieve pressure. Given her thrombocytopenia, thrombosis, significantly elevated D-dimer, low fibrinogen, and +HIT Ab test, she was diagnosed with vaccine-induced thrombocytopenia and thrombosis (VITT). She was started on IVIG 1g/kg daily  x 2 days,  bivalirudin with supportive transfusions to maintain goal plts >50K, fibrinogen > 150. Despite this, her neurologic status deteriorated due to elevated pressures, clotting off of her EVDs, and ultimately was declared brain dead in the afternoon on 9/7.  Family withdrew supportive care and patient passed at 3:57PM on 9/7/21.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Thrombosis, Thrombosis with thrombocytopenia syndrome
Clinical narrative: Patient presented to the ED around 10pm on 4/21, ~one week after her J&J COVID vaccine (exact date of initial vaccination not confirmed but was reportedly 1 week prior) with abdominal pain and headache. She was found to have thrombocytopenia (Plt 38) on presentation as well as renal and ovarian vein thrombosis. CT head showed a large right frontal intraparenchymal hemorrhage. She was taken for urgent craniotomy on 9/5 with EVD placement. Brain tissue was noted to have bleeding spots unresponsive to cautery and requiring local hemostatic agents. Repeat imaging showed worsening infarction. She had continued elevated intracranial pressures, so was taken back to the OR on the morning of 9/6 for bilateral EVD placement to help relieve pressure. Given her thrombocytopenia, thrombosis, significantly elevated D-dimer, low fibrinogen, and +HIT Ab test, she was diagnosed with vaccine-induced thrombocytopenia and thrombosis (VITT). She was started on IVIG 1g/kg daily  x 2 days,  bivalirudin with supportive transfusions to maintain goal plts >50K, fibrinogen > 150. Despite this, her neurologic status deteriorated due to elevated pressures, clotting off of her EVDs, and ultimately was declared brain dead in the afternoon on 9/7.  Family withdrew supportive care and patient passed at 3:57PM on 9/7/21.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral venous sinus thrombosis
Clinical narrative: Patient presented to the ED around 10pm on 4/21, ~one week after her J&J COVID vaccine (exact date of initial vaccination not confirmed but was reportedly 1 week prior) with abdominal pain and headache. She was found to have thrombocytopenia (Plt 38) on presentation as well as renal and ovarian vein thrombosis. CT head showed a large right frontal intraparenchymal hemorrhage. She was taken for urgent craniotomy on 9/5 with EVD placement. Brain tissue was noted to have bleeding spots unresponsive to cautery and requiring local hemostatic agents. Repeat imaging showed worsening infarction. She had continued elevated intracranial pressures, so was taken back to the OR on the morning of 9/6 for bilateral EVD placement to help relieve pressure. Given her thrombocytopenia, thrombosis, significantly elevated D-dimer, low fibrinogen, and +HIT Ab test, she was diagnosed with vaccine-induced thrombocytopenia and thrombosis (VITT). She was started on IVIG 1g/kg daily  x 2 days,  bivalirudin with supportive transfusions to maintain goal plts >50K, fibrinogen > 150. Despite this, her neurologic status deteriorated due to elevated pressures, clotting off of her EVDs, and ultimately was declared brain dead in the afternoon on 9/7.  Family withdrew supportive care and patient passed at 3:57PM on 9/7/21.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Activated partial thromboplastin time shortened, Antibody test positive, Anticoagulant therapy, Blood fibrinogen decreased
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Blood lactate dehydrogenase normal, Brain death, Cerebral haemorrhage, Computerised tomogram head abnormal, Craniotomy
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Death, Fibrin D dimer increased, Haemoglobin normal, Haemostasis, Haptoglobin normal
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, Heparin-induced thrombocytopenia test positive, Immunoglobulin therapy, Infarction, International normalised ratio increased
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Intracranial pressure increased, Neurological decompensation, Ovarian vein thrombosis, Platelet count decreased, Prothrombin time prolonged
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Renal vein thrombosis, Thrombocytopenia, Transfusion, Ventricular drainage, White blood cell count increased
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Withdrawal of life support
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Brain death, Cerebral haemorrhage, Cerebral mass effect, Death
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Decompressive craniectomy, Immunoglobulin therapy, Loss of consciousness, Thrombosis with thrombocytopenia syndrome, Unresponsive to stimuli
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Ventricular drainage
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Haemorrhage intracranial, Imaging procedure, Infarction, Laboratory test, Platelet count decreased
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Thrombosis, Thrombosis with thrombocytopenia syndrome
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral venous sinus thrombosis
Clinical narrative: Patient is believed to have Thrombosis with Thrombocytopenia Syndrome (also termed Vaccine-induced Thrombotic Thrombocytopenia) as the result of vaccination with the J&J COVID Vaccine.    She presented to the ED with loss of consciousness on 9/5 and found to have intraparenchymal hemorrhage and mass effect with midline shift and thrombocytopenia .   She was taken to the OR where she underwent  right hemicraniectomy with decompression of right frontal intraparenchymal hemorrhage and EVD placement.     Hematology was consulted who determined most likely cause of ICH was Vaccine-induced Thrombotic Thrombocytopenia.  The patient was treated with IVIG.  Aggressive medical management with hypertonic saline and mannitol was unable to bring ICP<20, so the patient was taken back to OR to place bilateral EVD on the morning of 9/6.   That afternoon the patient was started on bivalrudin.   On 9/7 was still unresponsive and brain death examinations were performed.   The patient was determined to be brain dead and pronounced dead on 9/7.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymphadenopathy in left armpit
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: A week after both shots I developed a rash that was all over my body
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Paraesthesia, Peripheral swelling
Clinical narrative: Swelling and tingling of vaccinated arm, light headed, dizzy.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Dizziness, Ear discomfort, Hyperhidrosis, Magnetic resonance imaging head
Clinical narrative: I blew my nose as I was walking through the kitchen and I heard something pop in my inner ear (left side). I called my wife to bring a chair to sit on. I thought it would go away but it didn't. I was sweating in the chest area and feeling a little nauseous. It was going on so long I called an ambulance and they took me to ER. At the Hospital ER they did a CT scan and said they couldn't find any event in my brain. I did not have a stroke. No treatment at the hospital - but the ambulance EMT's gave me something under my tongue which kind of cleared things up in a hurry. But because I was still sweating they took me to ER. They only gave me some medications (prescribed them) - Meclizine 25 mg - one tablet three times daily as needed for dizziness. I know it did something to my inner ear - but they were treating me for Vertigo but I think I it was just from blowing my nose too hard. They also prescribed Ondansetron ODT - 4 mg for nausea - I never took one of those.  I didn't have need of those. Meclizine that I was taking - I am not taking it any longer - I almost feel like I became addicted to it. I haven't really needed it for awhile.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vertigo
Clinical narrative: I blew my nose as I was walking through the kitchen and I heard something pop in my inner ear (left side). I called my wife to bring a chair to sit on. I thought it would go away but it didn't. I was sweating in the chest area and feeling a little nauseous. It was going on so long I called an ambulance and they took me to ER. At the Hospital ER they did a CT scan and said they couldn't find any event in my brain. I did not have a stroke. No treatment at the hospital - but the ambulance EMT's gave me something under my tongue which kind of cleared things up in a hurry. But because I was still sweating they took me to ER. They only gave me some medications (prescribed them) - Meclizine 25 mg - one tablet three times daily as needed for dizziness. I know it did something to my inner ear - but they were treating me for Vertigo but I think I it was just from blowing my nose too hard. They also prescribed Ondansetron ODT - 4 mg for nausea - I never took one of those.  I didn't have need of those. Meclizine that I was taking - I am not taking it any longer - I almost feel like I became addicted to it. I haven't really needed it for awhile.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Dizziness, Headache
Clinical narrative: When i woke up at 6:30 a.m i felt dizzy, light headed and weak. When i went to brush my teeth i felt that i was going to faint and so i sat down. After sitting for 5 minutes in the bathroom i went back to my bedroom to lay down to sleep again. Once i woke up at around 8.a.m i had joint pain  and a strong headache and lower back pain. This entire day i bedridden. The next day i felt great, i had no symptoms.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased
Clinical narrative: When i woke up at 6:30 a.m i felt dizzy, light headed and weak. When i went to brush my teeth i felt that i was going to faint and so i sat down. After sitting for 5 minutes in the bathroom i went back to my bedroom to lay down to sleep again. Once i woke up at around 8.a.m i had joint pain  and a strong headache and lower back pain. This entire day i bedridden. The next day i felt great, i had no symptoms.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram abnormal, Anticoagulant therapy, COVID-19, Hypoaesthesia, International normalised ratio
Clinical narrative: Patient admitted on 8/29/2021: Patient is a 70-year-old gentleman, who tested positive for COVID on Monday. He was treated with __________, has been at home and has been improving.  He said his onset of symptoms were the middle of last week.  This afternoon, he was walking when his right lower extremity became painful and then numb.  He has no antecedent claudication.  He came to the emergency room.  A CTA was performed, which shows a thrombus in the popliteal artery.  Patient discharged 9/1/2021: This is a 70-year-old gentleman, who is COVID positive that presented with acuteonset of right lower extremity pain, followed by numbness.  He underwent CTA that showed acute popliteal artery thrombosis with limb-threatening ischemia.  His foot was cool, pale, and beginning to become mottled with loss of sensation and movement and he also had absent Doppler signals below his groin.  It was felt that he would require emergent thrombectomy.  He was taken to the operating room on August 28th and underwent the above-stated procedure.  A long portion of acute thrombus was removed from his popliteal artery and below and he was noted to have good back bleeding and positive Doppler signals at the end of the case.  Postoperatively, he has done well.  He has been placed on warfarin therapy and currently is therapeutic with an INR in the 2-3 range.  We will alternate 7.5 and 5 mg of Coumadin daily. He is ambulating without difficulty.  His pain is controlled and he is ready for discharge home.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ischaemia, Mobility decreased, Pain in extremity, Pallor, Peripheral artery thrombosis
Clinical narrative: Patient admitted on 8/29/2021: Patient is a 70-year-old gentleman, who tested positive for COVID on Monday. He was treated with __________, has been at home and has been improving.  He said his onset of symptoms were the middle of last week.  This afternoon, he was walking when his right lower extremity became painful and then numb.  He has no antecedent claudication.  He came to the emergency room.  A CTA was performed, which shows a thrombus in the popliteal artery.  Patient discharged 9/1/2021: This is a 70-year-old gentleman, who is COVID positive that presented with acuteonset of right lower extremity pain, followed by numbness.  He underwent CTA that showed acute popliteal artery thrombosis with limb-threatening ischemia.  His foot was cool, pale, and beginning to become mottled with loss of sensation and movement and he also had absent Doppler signals below his groin.  It was felt that he would require emergent thrombectomy.  He was taken to the operating room on August 28th and underwent the above-stated procedure.  A long portion of acute thrombus was removed from his popliteal artery and below and he was noted to have good back bleeding and positive Doppler signals at the end of the case.  Postoperatively, he has done well.  He has been placed on warfarin therapy and currently is therapeutic with an INR in the 2-3 range.  We will alternate 7.5 and 5 mg of Coumadin daily. He is ambulating without difficulty.  His pain is controlled and he is ready for discharge home.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Peripheral coldness, SARS-CoV-2 test positive, Sensory loss, Thrombectomy, Ultrasound Doppler abnormal
Clinical narrative: Patient admitted on 8/29/2021: Patient is a 70-year-old gentleman, who tested positive for COVID on Monday. He was treated with __________, has been at home and has been improving.  He said his onset of symptoms were the middle of last week.  This afternoon, he was walking when his right lower extremity became painful and then numb.  He has no antecedent claudication.  He came to the emergency room.  A CTA was performed, which shows a thrombus in the popliteal artery.  Patient discharged 9/1/2021: This is a 70-year-old gentleman, who is COVID positive that presented with acuteonset of right lower extremity pain, followed by numbness.  He underwent CTA that showed acute popliteal artery thrombosis with limb-threatening ischemia.  His foot was cool, pale, and beginning to become mottled with loss of sensation and movement and he also had absent Doppler signals below his groin.  It was felt that he would require emergent thrombectomy.  He was taken to the operating room on August 28th and underwent the above-stated procedure.  A long portion of acute thrombus was removed from his popliteal artery and below and he was noted to have good back bleeding and positive Doppler signals at the end of the case.  Postoperatively, he has done well.  He has been placed on warfarin therapy and currently is therapeutic with an INR in the 2-3 range.  We will alternate 7.5 and 5 mg of Coumadin daily. He is ambulating without difficulty.  His pain is controlled and he is ready for discharge home.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Resting heart rate increased (130's) for a few hours, approximately 24 hours after the vaccine.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Got covid
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain
Clinical narrative: The first one i was itchy that night that was it.  The second one three days later getting these little twinges of chest pain every now and then. They seem to be fading away now, but still once in awhile.    Never sought treatment
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Neuralgia, Rash
Clinical narrative: Received 2-dose Modena COVID-19 vaccine on 12/30/2020 & 1/27/2021 (same lot and hospital administration).  Developed shingles on 7/31/2021 at age of 52.  Morning of 8/1/2021, evaluated within 12 hours of onset.  Given prescription for Valtrex 1000mg twice daily for 7 days.  Given Gabapentin pills and lidocaine cream for nerve pain.  Rash spread to cover 4" swatch from middle of back/spine to middle of front/midline just under shoulder and armpit.  Rash resolved after 7-10 days.  Nerve pain continued.  Refilled lidocaine cream on 8/23/2021.  Nerve pain still continues now 6 weeks after diagnosis.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Cognitive disorder, Computerised tomogram head normal, Fall, Laboratory test normal
Clinical narrative: Started with balance problem falling cognitive decline
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pt presented to clinic for 1st dose of Pfizer Covid-19 vaccination. Pt and Mother stated pt's birth date was 9/2/2009 and received a 1st dose of Pfizer covid-19 vaccine. Upon entering data into state registry, we discovered pt's birthdate is 9/20/2009. Mother confirmed birthdate was 9/20/2009 and stated she had lied on the paperwork. She was informed that her child will not receive a second dose until child was 12 years old.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Wheezing
Clinical narrative: Patient received Pfizer vaccine after allergy testing and was cleared to receive vaccine.  Approximately 30 minutes after dose given she started wheezing,  having difficulty breathing, and had satts of 70%.  She was given Epinephrine. Benadryl, and IV was started and she was given steroids.  She was then transported to the ER.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Full body rash.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Injected limb mobility decreased, Injection site pain, Magnetic resonance imaging joint, Magnetic resonance imaging spinal normal
Clinical narrative: In May of 2021 I suddenly developed a sore right shoulder and upper arm, this progressively got worse.  The issue appeared coincident with a common cold that I contracted while in out of town at my mother's funeral. My PCP referred me to Spine clinic, believing I may have a spinal issue, however an MRI of my thoracic spine was OK. As the pain progressed in my right shoulder/upper arm, I was losing range of motion and the pain was getting worse.  I was given Meloxicam 15mg to alleviate swelling, and referred to physical therapy.  My therapist noted that my range of motion limitations were not consistent with his experience with rotator cuff impingements, which is what I had been diagnosed with by Spine Clinic.  Subsequent visits at Spine clinic have resulted in an ultrasound of my right shoulder and an MRI. I then received a cortisone shot in my right shoulder about 4 weeks ago, and am for the moment pain free. I am still in PT. I have not yet talked to my PCP, I see her on September 30 for my annual physical. I contacted her today to tell her about my submission of this form. I submitted information regarding my rotator cuff impingement diagnosis in a vSafe report on Sunday 9/5 and was contacted by a CDC medical person on Tuesday 9/7 by phone, and asked to complete this online form.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: In May of 2021 I suddenly developed a sore right shoulder and upper arm, this progressively got worse.  The issue appeared coincident with a common cold that I contracted while in out of town at my mother's funeral. My PCP referred me to Spine clinic, believing I may have a spinal issue, however an MRI of my thoracic spine was OK. As the pain progressed in my right shoulder/upper arm, I was losing range of motion and the pain was getting worse.  I was given Meloxicam 15mg to alleviate swelling, and referred to physical therapy.  My therapist noted that my range of motion limitations were not consistent with his experience with rotator cuff impingements, which is what I had been diagnosed with by Spine Clinic.  Subsequent visits at Spine clinic have resulted in an ultrasound of my right shoulder and an MRI. I then received a cortisone shot in my right shoulder about 4 weeks ago, and am for the moment pain free. I am still in PT. I have not yet talked to my PCP, I see her on September 30 for my annual physical. I contacted her today to tell her about my submission of this form. I submitted information regarding my rotator cuff impingement diagnosis in a vSafe report on Sunday 9/5 and was contacted by a CDC medical person on Tuesday 9/7 by phone, and asked to complete this online form.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Confusional state, Disturbance in attention, Feeling cold, Hypoaesthesia
Clinical narrative: Hypotension tachycardia numb arms and hands loss of function of arm and hand TIA severe cold and shaking rigors extreme muscle aches resulting in being bedridden for 24 hours color of hands change to white with painful cold confusion and inability to focus or concentrate lethargic and inability to move
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Lethargy, Mobility decreased, Myalgia, Pain in extremity
Clinical narrative: Hypotension tachycardia numb arms and hands loss of function of arm and hand TIA severe cold and shaking rigors extreme muscle aches resulting in being bedridden for 24 hours color of hands change to white with painful cold confusion and inability to focus or concentrate lethargic and inability to move
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral coldness, Skin discolouration, Tachycardia, Transient ischaemic attack, Tremor
Clinical narrative: Hypotension tachycardia numb arms and hands loss of function of arm and hand TIA severe cold and shaking rigors extreme muscle aches resulting in being bedridden for 24 hours color of hands change to white with painful cold confusion and inability to focus or concentrate lethargic and inability to move
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Pain, Pain in extremity, Somnolence
Clinical narrative: 09/06 took Tylenol after the vaccine  09/07  Am. Increased temp.,  99.9 I took Tylenol again. By  about 12:00 the cough started I started to feel achy  in my arms and legs. By  about 6:00 Pm the chills started but went away after I went to bed. Slept through the night when I woke up my temp was 100.2 my usual temperature is 97.4 ish.  The aches started non stop I slept all day 3:37 and I took Tylenol half hour ago still high temp.  I take GALYNIA  for my MS .
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Dissociation, Dysstasia, Emotional disorder, Feeling abnormal, Headache
Clinical narrative: "The day after the 2nd dose, I began feeling sick and was experiencing emotional problems. I had a headache and nausea. I began having bad thoughts, with thoughts of self-harm and feeling that I wanted to die. I was very tearful, felt very spacy and dissociated, and had difficulty standing."
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Nausea, Tearfulness, Thinking abnormal
Clinical narrative: "The day after the 2nd dose, I began feeling sick and was experiencing emotional problems. I had a headache and nausea. I began having bad thoughts, with thoughts of self-harm and feeling that I wanted to die. I was very tearful, felt very spacy and dissociated, and had difficulty standing."
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Eye haemorrhage
Clinical narrative: Busted blood vessel in lower left eye.  There is a bright red spot under pupil.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Chest pain, Echocardiogram, Echocardiogram normal, Electrocardiogram
Clinical narrative: 09/04/21  9:00am fever aches headache 09/05/21 dull headache and fatigue most of day 09/06/21 5:00 am chest pains few hours while laying 09/07/21 3:30 am chest pain radiating to both arms while laying 09/07/21 8am called physician 10am ER 09/07/21 6pm transferred to hospital - myocarditis: high cardiac markers 09/07-08/21  Echo, enormal
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myocardial necrosis marker increased, Myocarditis, Pain
Clinical narrative: 09/04/21  9:00am fever aches headache 09/05/21 dull headache and fatigue most of day 09/06/21 5:00 am chest pains few hours while laying 09/07/21 3:30 am chest pain radiating to both arms while laying 09/07/21 8am called physician 10am ER 09/07/21 6pm transferred to hospital - myocarditis: high cardiac markers 09/07-08/21  Echo, enormal
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: 09/04/21  9:00am fever aches headache 09/05/21 dull headache and fatigue most of day 09/06/21 5:00 am chest pains few hours while laying 09/07/21 3:30 am chest pain radiating to both arms while laying 09/07/21 8am called physician 10am ER 09/07/21 6pm transferred to hospital - myocarditis: high cardiac markers 09/07-08/21  Echo, enormal
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Eye discharge, Eye swelling, Rash
Clinical narrative: Rash on entire body. The worst areas being the armpits. Left eye swollen shut with lots of discharge but both eyes irritated.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Lip swelling, Streptococcus test negative, Symptom recurrence, Throat tightness, Urticaria
Clinical narrative: Developed urticaria to entire body on 9/5/21.  Given Allegra by mother.  Taken to ER on 9/6/21 due to sensation of tightness in throat, given Benadryl and Prednisone.  Taken back to ER on 9/7/21 for recurrence of symptoms, prescribed 5 days of prednisone and Epipen, but was not given epinephrine.  Described some lip swelling during the event along with urticaria.  No vomiting or respiratory symptoms apart from sensation in throat.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angina pectoris, Chest pain, Pain
Clinical narrative: Four days after the first dose, she started feeling a pinch or prick type of pain in her heart/chest area that radiated out and slowly dissipated. It would last a few minutes and happen without a specific interval several times a day for about four days.  After that, it didn?t happen again. We wanted to go to urgent care, but at the end didn?t go.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angina pectoris
Clinical narrative: Four days after the first dose, she started feeling a pinch or prick type of pain in her heart/chest area that radiated out and slowly dissipated. It would last a few minutes and happen without a specific interval several times a day for about four days.  After that, it didn?t happen again. We wanted to go to urgent care, but at the end didn?t go.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling, Joint range of motion decreased, Loss of personal independence in daily activities
Clinical narrative: Injection site pain and inflammation on 7-8 September 2021, four months after receiving second dose of vaccine. Had very mild pain during first injection that lasted less than 5 minutes and no pain with second injection. Woke up from sleep on 7 September with similar pain as experienced after first injection but much stronger, accompanied with swelling. Pain increased with movement of arm and movement was limited. Responds well to ibuprofen and but has persisted for two days and required frequent re-dosing of ibuprofen.  Severe enough to impact daily activities but not severe enough to seek further medical attention.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Injection site pain and inflammation on 7-8 September 2021, four months after receiving second dose of vaccine. Had very mild pain during first injection that lasted less than 5 minutes and no pain with second injection. Woke up from sleep on 7 September with similar pain as experienced after first injection but much stronger, accompanied with swelling. Pain increased with movement of arm and movement was limited. Responds well to ibuprofen and but has persisted for two days and required frequent re-dosing of ibuprofen.  Severe enough to impact daily activities but not severe enough to seek further medical attention.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, Anticoagulant therapy, COVID-19, Catheter site haemorrhage
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 2/25/2021 and 3/23/2021. Presented to the ED on 8/11/2021 for asymptomatic testing so he may resume dialysis. On 8/14/2021 patient returns to ED with a two day history of fatigue, nausea, vomiting, diarrhea, chills, body aches, and loss of taste and smell. Denies shortness of breath, headache or chest pain, Has O2 sats of 100%. Patient was discharged from ED with instructions to return if dyspnea occurs. On 8/17/2021 patient returns to ED with shortness of breath and sepsis secondary to infected dialysis catheter (MSSA bacteremia). Treated with dexamethasone, heparin prophylaxis dosing, zosyn, and vancomycin. Antibiotics were later changed to cefazolin once culture and sensitivity resulted. Patient also developed bleeding from catheter site. he eventually succumbed to multiple acute illnesses with multiorgan failure.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Culture, Death, Device related infection, Diarrhoea
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 2/25/2021 and 3/23/2021. Presented to the ED on 8/11/2021 for asymptomatic testing so he may resume dialysis. On 8/14/2021 patient returns to ED with a two day history of fatigue, nausea, vomiting, diarrhea, chills, body aches, and loss of taste and smell. Denies shortness of breath, headache or chest pain, Has O2 sats of 100%. Patient was discharged from ED with instructions to return if dyspnea occurs. On 8/17/2021 patient returns to ED with shortness of breath and sepsis secondary to infected dialysis catheter (MSSA bacteremia). Treated with dexamethasone, heparin prophylaxis dosing, zosyn, and vancomycin. Antibiotics were later changed to cefazolin once culture and sensitivity resulted. Patient also developed bleeding from catheter site. he eventually succumbed to multiple acute illnesses with multiorgan failure.